amlodipine has been researched along with benazepril in 101 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 9 (8.91) | 18.2507 |
| 2000's | 61 (60.40) | 29.6817 |
| 2010's | 31 (30.69) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Sun, H | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chan, K; Cipriano, A; John, VA; Sun, JX | 1 |
| Arita, M; Frohlich, ED; Horinaka, S | 1 |
| Chrysant, SG; Frishman, WH; Graff, A; Hsu, H; Kupiec, JW; McMahon, FG; RAM, CV | 1 |
| Kountz, DS | 1 |
| Fogari, R; Lusardi, P; Motolese, M; Mugellini, A; Preti, P; Zoppi, A | 1 |
| Bentivoglio, M; Bertocchi, F; Cardoni, O; Corea, L; Cosmi, F; Fogari, R; Innocenti, P; Porcellati, C; Provvidenza, M; Timio, M; Zoppi, A | 1 |
| Bakris, GL; Bidani, AK; Griffin, KA; Picken, MM | 1 |
| Doba, N; Kimura, Y; Kinouchi, T; Kushiro, T; Mitsuhashi, H; Tomiyama, H; Yoshida, H | 1 |
| Hilleman, DE; Mohiuddin, SM; Ryschon, KL; Wurdeman, RL | 1 |
| Feng, Z; Messerli, FH; Oparil, S | 1 |
| Kanno, Y; Okada, H; Saruta, T; Suzuki, H | 1 |
| Faulkner, MA; Hilleman, DE | 1 |
| Ginsberg, D; Glazer, R; Kaihlanen, P; Lewis, G; Messerli, FH; Oparil, S; Pool, J | 1 |
| Faulkner, M; Hilleman, DE; Reyes, AP; Wurdeman, RL | 1 |
| Bakris, GL; Epstein, M; Goldberg, R; Hung, E; Preston, R; Richardson, DJ; Smith, AC | 1 |
| Messerli, FH; Neutel, JM; Weir, MR | 1 |
| Bertocchi, F; Carretta, R; Di Somma, S; Malacco, E; Mugellini, A; Palatini, P; Piazza, S | 1 |
| Caro, JJ; Lee, K | 1 |
| Kanno, Y; Moriwaki, K; Nagao, S; Okada, H; Suzuki, H; Takahashi, H | 1 |
| He, BR; Li, L; Wang, Y | 1 |
| Fogari, R; Malamani, GD; Mugellini, A; Preti, P; Rinaldi, A; Vanasia, A; Zoppi, A | 1 |
| Corradi, L; Fogari, E; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Zoppi, A | 1 |
| DiCesare, J; Doan, QD; Floyd, K; Sacco, P; Sapienza, S | 1 |
| Böhm, M; Hammer, B; Link, A; Weisgerber, K | 1 |
| Neutel, JM; Smith, DH; Weber, MA | 1 |
| Imai, H; Ishida, Y; Nakamoto, H; Suzuki, H; Tomori, K | 1 |
| Baron, M; Jamerson, KA; Jean-Louis, L; Nwose, O; Purkayastha, D; Schofield, L | 1 |
| Bakris, GL; Chrysant, SG | 1 |
| Bakris, GL; McCullough, PA; Toto, RD | 1 |
| Weder, AB | 1 |
| Efstathiou, S; Makris, T; Manolis, A; Papavasiliou, M; Stergiou, GS | 1 |
| Meyyanathan, SN; Suresh, B | 1 |
| Bakris, GL; Bard, M; Folker, A; Hung, E; Murphy, JA; Perkelvald, A; Sowers, JR; Winer, N | 1 |
| Kale, UN; Naidu, KR; Shingare, MS | 1 |
| Gatlin, M; Neutel, JM; Purkayastha, D; Schofield, L; Smith, DH; Weber, MA | 1 |
| Koenig, M; Rafii, MS; Ziai, WC | 1 |
| Chavanu, K; Merkel, J; Quan, A | 1 |
| Siragy, HM; Webb, RL; Xue, C | 1 |
| Jaimes, EA; Raij, L; Zhou, MS | 1 |
| Barker, TA; Berk, BC; Kennedy, AJ; Korshunov, VA; Massett, MP; Mohan, AM | 1 |
| Davis, P; Gatlin, M; Herrington, D; Mangano, C; Mohler, ER; Ouyang, P; Purkayastha, D; Ritter, S; Vogel, RA | 1 |
| Blatt, C; Korsten, MA; Motwani, P; Shahzad, G | 1 |
| Bakris, GL; Dahlöf, B; Gupte, J; Hester, A; Jamerson, K; Kjeldsen, S; Lefkowitz, M; Massie, B; Nesbitt, S; Ofili, E; Pitt, B; Shi, V; Velazquez, E; Weber, MA; Weir, M | 1 |
| Arora, V; Chrysant, SG; Khan, M; Lefkowitz, M; Salko, T; Shi, V; Sugimoto, DH | 1 |
| Bakris, GL; Cushman, W; Dahlöf, B; Gupte, J; Hester, A; Jamerson, K; Kjeldsen, SE; Lefkowitz, M; Papademetriou, V; Pitt, B; Shi, V; Velazquez, E; Weber, M | 1 |
| Dubiel, R; Kereiakes, DJ; Lipka, LJ; Neutel, JM; Punzi, HA; Xu, J | 1 |
| Hu, ZJ; Liu, DL; Wang, MP; Wu, G; Wu, J; Xu, GY | 1 |
| Dickson, M; Plauschinat, CA | 1 |
| Bakris, GL; Davis, P; McCullough, PA; Purkayastha, D; Rocha, R; Toto, RD | 1 |
| Einecke, D | 1 |
| Bakris, GL; Dahlöf, B; Gupte, J; Hester, A; Hua, TA; Ibsen, H; Jamerson, KA; Kjeldsen, SE; Ostergren, J; Pitt, B; Shi, V; Staikos, L; Tuomilehto, J; Velazquez, EJ; Weber, M | 1 |
| Hedner, T; Kjeldsen, SE; Narkiewicz, K; Oparil, S | 1 |
| Aumiller, J | 1 |
| Chang, PY; Chen, WL; Lai, WT; Lin, CS; Lin, LC; Lin, MC; Lin, TH; Liu, YB; Su, HM; Ueng, KC; Voon, WC; Wu, CC | 1 |
| Bakris, G; Dahlof, B; Hester, A; Jamerson, K; Pitt, B; Shi, V; Staikos-Byrne, L; Velasquez, E; Weber, M | 1 |
| Bakris, GL; Dahlöf, B; Gatlin, M; Gupte, J; Hester, A; Jamerson, K; Pitt, B; Shi, V; Velazquez, EJ; Weber, MA | 1 |
| Chobanian, AV | 1 |
| Bacher, P; Champion, A; Fakouhi, K; Tian, M; Toto, RD | 1 |
| Basile, JN; Carter, BL; Ernst, ME | 1 |
| Feihl, F; Waeber, B | 1 |
| Cohen, DL; Townsend, RR | 1 |
| Preobrazhenskiĭ, DV | 1 |
| Parra, D; Rosenstein, R | 1 |
| Newton, GE; Strauss, MH; Weinstein, J | 1 |
| Davis, BR; Whelton, PK | 1 |
| Krzesinski, JM; Scheen, AJ | 1 |
| Siragy, HM | 1 |
| Devereux, RB; Hall, D; Hilkert, R; Pitt, B; Purkayastha, D; Reichek, N; Rocha, RA | 1 |
| Hall, D; Hilkert, RJ; Izzo, JL; Purkayastha, D | 1 |
| Farooqui, MN; Kasawar, GB | 1 |
| Bakris, GL; Chiang, YT; Dahlöf, B; Jamerson, K; Kelly, RY; Pitt, B; Sarafidis, PA; Shi, V; Staikos-Byrne, L; Velazquez, EJ; Weber, MA; Weir, MR | 1 |
| de Zeeuw, D; Heerspink, HL | 1 |
| White, WB | 1 |
| Bakris, GL; Jamerson, KA; Weber, MA | 1 |
| Bakris, GL; Dahlöf, B; Devereux, RB; Hester, A; Hua, TA; Jamerson, K; Kelly, RY; Kjeldsen, SE; Pitt, B; Velazquez, EJ; Weber, MA; Weir, M | 1 |
| Inamadugu, JK; Karra, VK; Mullangi, R; Pilli, NR; Rao, JV; Vaidya, JR | 1 |
| Bakris, GL; Dahlöf, B; Devereux, R; Hester, A; Hua, TA; Jamerson, KA; Kelly, RY; Pitt, B; Velazquez, EJ; Weber, MA; Weir, M | 1 |
| Fan, CM; Gao, MM; Li, CX; Li, YQ; Li, YS; Lu, XL; Pang, HM; Tao, YK; Wang, L; Wang, XW; Wang, YN; Yan, LR | 1 |
| Bakris, GL; Dahlöf, B; Hester, A; Hua, TA; Ibsen, H; Jamerson, KA; Kelly, RY; Kjeldsen, SE; Ostergren, J; Pitt, B; Tuomilehto, J; Velazquez, EJ; Weber, M; Zappe, D | 1 |
| Bakris, GL; Dahlof, B; Devereux, RB; Hester, RA; Hua, TA; Jamerson, KA; Kelly, RY; Kjeldsen, SE; Pitt, B; Velazquez, E; Weber, MA; Weir, MR; Wright, JT | 1 |
| Chrysant, SG | 1 |
| Chen, JF; Hung, YJ; Lee, IT; Lee, WJ; Sheu, WH; Wang, CY | 2 |
| Fukushima, R; Hamabe, L; Ishikawa, T; Kim, S; Machida, N; Suzuki, S; Tanaka, R; Yamamoto, Y; Yoshiyuki, R | 1 |
| Bakris, GL; Dahlof, B; Jamerson, K; Pitt, B; Velazquez, EJ; Weber, MA; Weir, MR; Zappe, D; Zhang, Y | 1 |
| Bakris, G; Briasoulis, A; Dahlof, B; Hester, A; Hua, T; Jamerson, K; Kelly, RY; Pitt, B; Weber, MA; Zappe, D | 1 |
| Fan, W; Yan, P | 1 |
| Elaziz, OA; Farouk, M; Hemdan, A; Shehata, MA; Tawakkol, SM | 1 |
| Bakris, G; Byrd, JB; Jamerson, K | 1 |
| Chen, XY; Ding, JF; Lin, LS; Pan, HL; Zhong, DF | 1 |
| Badr, KA; Rezk, MR | 1 |
| Asp, J; Dahlöf, B; Jamerson, KA; Jia, Y; Kjeldsen, SE; Östergren, J; Skoglund, PH; Svensson, P; Weber, MA; Zappe, DH | 1 |
| Bedirian, R; Gismondi, RA; Ladeira, MC; Neves, MF; Oigman, W; Pozzobon, CR | 1 |
| Hemdan, A | 1 |
| Bakris, G; Brook, RD; Dahlöf, B; Hau, T; Jamerson, KA; Kaciroti, N; Pitt, B; Velazquez, E; Weber, M; Zappe, DH | 1 |
| Davidson, MG; Westermeyer, HD; Young, WM; Zheng, C | 1 |
| Chen, L; Dou, RH; Hu, JH; Jin, H; Liu, FL; Liu, ZJ; Wen, XY; Xu, HQ; Yan, CL; Zhang, QJ | 1 |
| Habara, M; Haraguchi, T; Ikezaki, H; Kojima, H; Nakamura, S; Uchida, T; Yoshida, M | 1 |
5 review(s) available for amlodipine and benazepril
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Fixed-dose combination vs monotherapy in hypertension: a meta-analysis evaluation.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Drug Combinations; Humans; Hypertension; Lisinopril; Treatment Outcome; Verapamil | 1999 |
Amlodipine/benazepril: fixed dose combination therapy for hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Clinical Trials as Topic; Drug Combinations; Humans; Hypertension; Treatment Outcome | 2001 |
A review of the efficacy of fixed-dose combinations olmesartan medoxomil/hydrochlorothiazide and amlodipine besylate/benazepril in factorial design studies.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Factor Analysis, Statistical; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Olmesartan Medoxomil; Randomized Controlled Trials as Topic; Tetrazoles | 2006 |
The contribution of the ACCOMPLISH trial to the treatment of stage 2 hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Diuretics; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Randomized Controlled Trials as Topic | 2014 |
53 trial(s) available for amlodipine and benazepril
| Article | Year |
|---|---|
Pharmacokinetic interaction study between benazepril and amlodipine in healthy subjects.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Cross-Over Studies; Drug Interactions; Humans; Male; Middle Aged | 1994 |
Comparison of amlodipine and benazepril monotherapy to amlodipine plus benazepril in patients with systemic hypertension: a randomized, double-blind, placebo-controlled, parallel-group study. The Benazepril/Amlodipine Study Group.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 1995 |
Fixed combination of benazepril and low-dose amlodipine in the treatment of mild to moderate essential hypertension: evaluation by 24-hour noninvasive ambulatory blood pressure monitoring.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Double-Blind Method; Drug Combinations; Humans; Hypertension; Male; Middle Aged | 1997 |
Combined therapy with benazepril and amlodipine in the treatment of hypertension inadequately controlled by an ACE inhibitor alone.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Dose-Response Relationship, Drug; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Placebos | 1997 |
Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Single-Blind Method | 2000 |
Blood pressure reduction associated with preservation of renal function in hypertensive patients with IgA nephropathy: a 3-year follow-up.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Creatinine; Drug Administration Schedule; Female; Follow-Up Studies; Glomerulonephritis, IGA; Humans; Hypertension; Male | 2000 |
Once-daily treatment of patients with hypertension: a placebo-controlled study of amlodipine and benazepril vs amlodipine or benazepril alone.
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzazepines; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2001 |
Impact of an ACE inhibitor and calcium antagonist on microalbuminuria and lipid subfractions in type 2 diabetes: a randomised, multi-centre pilot study.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Apolipoproteins; Apoprotein(a); Benzazepines; Calcium Channel Blockers; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Dihydropyridines; Female; Humans; Lipoprotein(a); Male; Middle Aged; Pilot Projects; Triglycerides | 2002 |
Combination therapy of amlodipine/benazepril versus monotherapy of amlodipine in a practice-based setting.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Drug Combinations; Edema; Female; Humans; Hypertension; Male; Middle Aged; Treatment Outcome | 2002 |
Comparison of benazepril-amlodipine and captopril-thiazide combinations in the management of mild-to-moderate hypertension.
Topics: Administration, Oral; Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Captopril; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged | 2002 |
[CEA comprehensive evaluation for Western and traditional Chinese hypotensive drugs].
Topics: Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzazepines; Cost-Benefit Analysis; Drugs, Chinese Herbal; Female; Humans; Hypertension; Indapamide; Male; Middle Aged; Phytotherapy; Quality of Life | 2001 |
Effect of benazepril addition to amlodipine on ankle oedema and subcutaneous tissue pressure in hypertensive patients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Ankle; Benzazepines; Calcium Channel Blockers; Cross-Over Studies; Diagnostic Techniques, Cardiovascular; Double-Blind Method; Drug Therapy, Combination; Edema; Female; Humans; Hydrostatic Pressure; Hypertension; Male; Middle Aged | 2003 |
Effect of benazepril amlodipine combination on fibrinolysis in hypertensive diabetic patients.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fibrinolysis; Humans; Hypertension; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Single-Blind Method; Tissue Plasminogen Activator | 2003 |
Results of a pilot pharmacotherapy quality improvement program using fixed-dose, combination amlodipine/benazepril antihypertensive therapy in a long-term care setting.
Topics: Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Cost Savings; Drug Combinations; Female; Humans; Hypertension; Long-Term Care; Male; Middle Aged; Pilot Projects; Quality Assurance, Health Care; Treatment Outcome | 2003 |
Effect of antihypertensive monotherapy and combination therapy on arterial distensibility and left ventricular mass.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Drug Therapy, Combination; Female; Heart Ventricles; Humans; Hypertension; Hypertrophy, Left Ventricular; Male; Middle Aged; Prospective Studies; Treatment Outcome; Vascular Capacitance; Vascular Resistance | 2004 |
Initial angiotensin-converting enzyme inhibitor/calcium channel blocker combination therapy achieves superior blood pressure control compared with calcium channel blocker monotherapy in patients with stage 2 hypertension.
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Evaluation; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Male; Middle Aged; Severity of Illness Index; Systole; Treatment Outcome | 2004 |
Amlodipine/benazepril combination therapy for hypertensive patients nonresponsive to benazepril monotherapy.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Diastole; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Systole; Time Factors; Treatment Outcome; United States | 2004 |
Rationale and design of a study comparing two fixed-dose combination regimens to reduce albuminuria in patients with type II diabetes and hypertension.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Renin-Angiotensin System; Research Design; Sodium Chloride Symporter Inhibitors | 2005 |
Comparison of antihypertensive effects of an angiotensin-converting enzyme inhibitor, a calcium antagonist and a diuretic in patients with hypertension not controlled by angiotensin receptor blocker monotherapy.
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Chlorthalidone; Cross-Over Studies; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Tetrazoles; Treatment Outcome; Valine; Valsartan | 2005 |
Effect of fixed-dose ACE-inhibitor/calcium channel blocker combination therapy vs. ACE-inhibitor monotherapy on arterial compliance in hypertensive patients with type 2 diabetes.
Topics: Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cohort Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Drug Therapy, Combination; Enalapril; Female; Humans; Hypertension; Male; Middle Aged; Natriuresis; Vascular Resistance | 2005 |
Efficacy of combination therapy for systolic blood pressure in patients with severe systolic hypertension: the Systolic Evaluation of Lotrel Efficacy and Comparative Therapies (SELECT) study.
Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Benzazepines; Blood Pressure Monitoring, Ambulatory; Chi-Square Distribution; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Systole; Treatment Outcome | 2005 |
A randomized, double-blind trial comparing the effects of amlodipine besylate/benazepril HCl vs amlodipine on endothelial function and blood pressure.
Topics: Aged; Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Biomarkers; Blood Flow Velocity; Blood Pressure; Brachial Artery; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Endothelium, Vascular; Female; Humans; Hypertension; Male; Middle Aged; Risk Factors; Severity of Illness Index; Treatment Outcome; United States; Vasodilation | 2006 |
Baseline characteristics in the Avoiding Cardiovascular events through Combination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a hypertensive population at high cardiovascular risk.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Body Mass Index; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Myocardial Infarction; Patient Selection; Scandinavian and Nordic Countries; Stroke; United States | 2007 |
The effects of high-dose amlodipine/benazepril combination therapies on blood pressure reduction in patients not adequately controlled with amlodipine monotherapy.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged | 2007 |
Exceptional early blood pressure control rates: the ACCOMPLISH trial.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2007 |
Efficacy and safety of olmesartan medoxomil and hydrochlorothiazide compared with benazepril and amlodipine besylate.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Diastole; Drug-Related Side Effects and Adverse Reactions; Female; Goals; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Male; Middle Aged; Olmesartan Medoxomil; Systole; Tetrazoles; Treatment Outcome | 2007 |
[Effect of atorvastatin on carotid intima-medial of thickness of primary hypertension patients of Han nationality in China].
Topics: Aged; Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzazepines; Carotid Arteries; China; Cholesterol, LDL; Dose-Response Relationship, Drug; Drug Therapy, Combination; Endothelium, Vascular; Female; Heptanoic Acids; Humans; Hypertension; Male; Middle Aged; Pyrroles; Time Factors; Treatment Outcome; Tunica Intima; Tunica Media | 2007 |
Effects of different ACE inhibitor combinations on albuminuria: results of the GUARD study.
Topics: Adult; Aged; Aged, 80 and over; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Treatment Outcome | 2008 |
Predictors of blood pressure response to intensified and fixed combination treatment of hypertension: the ACCOMPLISH study.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Drug Therapy, Combination; Female; Finland; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Multivariate Analysis; Predictive Value of Tests; Racial Groups; Risk Assessment; Scandinavian and Nordic Countries; Treatment Outcome; United States | 2008 |
An eight-week, multicenter, randomized, double-blind study to evaluate the efficacy and tolerability of fixed-dose amlodipine/benazepril combination in comparison with amlodipine as first-line therapy in chinese patients with mild to moderate hypertension
Topics: Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged | 2008 |
The diabetes subgroup baseline characteristics of the Avoiding Cardiovascular Events Through Combination Therapy in Patients Living With Systolic Hypertension (ACCOMPLISH) trial.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Prevalence; Time Factors; Treatment Outcome; United States | 2008 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Kaplan-Meier Estimate; Male; Middle Aged; Risk | 2008 |
Effects of calcium channel blockers on proteinuria in patients with diabetic nephropathy.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Indoles; Male; Middle Aged; Prospective Studies; Proteinuria; Treatment Outcome; Verapamil | 2008 |
[Is the combination of benazepril and amlodipine more effective in hypertension than the combination of benazepril and hydrochlorothiazide? Results of the ACCOMPLISH trial].
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Treatment Outcome | 2009 |
ACCOMPLISH the goal: hypertension and beyond.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Risk Assessment | 2009 |
Magnetic resonance imaging left ventricular mass reduction with fixed-dose angiotensin-converting enzyme inhibitor-based regimens in patients with high-risk hypertension.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Heart Ventricles; Humans; Hydrochlorothiazide; Hypertension; Hypertrophy, Left Ventricular; Magnetic Resonance Imaging; Male; Middle Aged; Risk Factors; Sex Characteristics; Treatment Outcome | 2009 |
Comparative efficacy and safety of amlodipine/benazepril combination therapy and amlodipine monotherapy in severe hypertension.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amlodipine; Antihypertensive Agents; Benzazepines; Chronic Disease; Diabetes Complications; Drug Therapy, Combination; Edema; Female; Humans; Hypertension; Kidney Diseases; Male; Middle Aged; Treatment Outcome; Young Adult | 2010 |
Renal outcomes with different fixed-dose combination therapies in patients with hypertension at high risk for cardiovascular events (ACCOMPLISH): a prespecified secondary analysis of a randomised controlled trial.
Topics: Aged; Albuminuria; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Creatinine; Disease Progression; Diuretics; Double-Blind Method; Drug Combinations; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Male; Middle Aged; Risk Factors | 2010 |
24-hour ambulatory blood pressure in the ACCOMPLISH trial.
Topics: Amlodipine; Analysis of Variance; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2010 |
Cardiovascular events during differing hypertension therapies in patients with diabetes.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Coronary Disease; Diabetes Complications; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Risk Factors | 2010 |
Efficacy and duration of benazepril plus amlodipine or hydrochlorothiazide on 24-hour ambulatory systolic blood pressure control.
Topics: Aged; Amlodipine; Analysis of Variance; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Male; Middle Aged; Prospective Studies; Time Factors; Treatment Outcome | 2011 |
[Comparison of benazepril monotherapy to amlodipine plus benazepril in the treatment of patients with mild and moderate hypertension: a multicentre, randomized, double-blind, parallel-controlled study].
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Double-Blind Method; Drug Combinations; Female; Humans; Hypertension; Male; Middle Aged | 2011 |
Predictors of systolic BP <140 mmHg and systolic BP level by randomly assigned treatment group (benazepril plus amlodipine or hydrochlorothiazide) in the ACCOMPLISH Study.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Drug Therapy, Combination; Electrocardiography; Female; Humans; Hydrochlorothiazide; Hypertension; Logistic Models; Male; Systole | 2012 |
Renal outcomes in hypertensive Black patients at high cardiovascular risk.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Biomarkers; Black or African American; Blood Pressure; Calcium Channel Blockers; Cardiovascular Diseases; Chi-Square Distribution; Creatinine; Diuretics; Double-Blind Method; Drug Therapy, Combination; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Incidence; Kaplan-Meier Estimate; Kidney; Kidney Failure, Chronic; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Risk Assessment; Risk Factors; Time Factors; Treatment Outcome; United States; Up-Regulation | 2012 |
Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Black People; Blood Pressure; Calcium Channel Blockers; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Single-Blind Method; White People | 2012 |
Comparison of the efficacy and safety profiles of two fixed-dose combinations of antihypertensive agents, amlodipine/benazepril versus valsartan/hydrochlorothiazide, in patients with type 2 diabetes mellitus and hypertension: a 16-week, multicenter, rando
Topics: Aged; Albuminuria; Amlodipine; Analysis of Variance; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Biomarkers; Blood Glucose; Blood Pressure; Calcium Channel Blockers; Diabetes Mellitus, Type 2; Diuretics; Double-Blind Method; Drug Combinations; Female; Glycated Hemoglobin; Humans; Hydrochlorothiazide; Hypertension; Lipids; Male; Middle Aged; Prospective Studies; Taiwan; Tetrazoles; Time Factors; Treatment Outcome; Uric Acid; Valine; Valsartan | 2012 |
Comparative effects of amlodipine and benazepril on left atrial pressure in dogs with experimentally-induced mitral valve regurgitation.
Topics: Amlodipine; Animals; Antihypertensive Agents; Atrial Function, Left; Benzazepines; Blood Pressure; Dogs; Echocardiography; Female; Male; Mitral Valve Insufficiency | 2012 |
Effects of body size and hypertension treatments on cardiovascular event rates: subanalysis of the ACCOMPLISH randomised controlled trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Body Mass Index; Body Size; Body Weight; Cardiovascular Diseases; Double-Blind Method; Drug Combinations; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Obesity | 2013 |
Comparison of benazepril plus amlodipine or hydrochlorothiazide in high-risk patients with hypertension and coronary artery disease.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Coronary Artery Disease; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Prospective Studies; Risk Assessment | 2013 |
The efficacy and safety of fixed-dose combination of amlodipine/benazepril in Chinese essential hypertensive patients not adequately controlled with benazepril monotherapy: a multicenter, randomized, double-blind, double-dummy, parallel-group clinical tri
Topics: Adolescent; Adult; Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Calcium Channel Blockers; China; Dose-Response Relationship, Drug; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Prevalence; Treatment Outcome; Young Adult | 2014 |
Amlodipine+benazepril is superior to hydrochlorothiazide+benazepril irrespective of baseline pulse pressure: subanalysis of the ACCOMPLISH trial.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Incidence; Male; Middle Aged; Myocardial Infarction; Retrospective Studies; Risk Factors; Stroke; Treatment Outcome | 2015 |
Assessment of glomerular filtration rate based on alterations of serum brain-derived neurotrophic factor in type 2 diabetic subjects treated with amlodipine/benazepril or valsartan/hydrochlorothiazide.
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Brain-Derived Neurotrophic Factor; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Female; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Male; Middle Aged; Valsartan | 2015 |
Renin-Angiotensin System Blockade Associated with Statin Improves Endothelial Function in Diabetics.
Topics: Amino Acids; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Brachial Artery; Diabetes Mellitus, Type 2; Endothelium, Vascular; Female; Humans; Hypertension; Losartan; Male; Middle Aged; Pulse Wave Analysis; Renin-Angiotensin System; Statistics, Nonparametric; Time Factors; Treatment Outcome; Vascular Stiffness | 2015 |
43 other study(ies) available for amlodipine and benazepril
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Capture hydrolysis signals in the microsomal stability assay: molecular mechanisms of the alkyl ester drug and prodrug metabolism.
Topics: Carboxylic Acids; Cytochrome P-450 Enzyme System; Esters; Humans; Hydrolysis; Microsomes; Models, Molecular; Molecular Structure; Prodrugs; Quantum Theory; Signal Transduction | 2012 |
Biochemical components and myocardial performance after reversal of left ventricular hypertrophy in spontaneously hypertensive rats.
Topics: Amlodipine; Animals; Benzazepines; Collagen; Drug Combinations; Hemodynamics; Hypertension; Hypertrophy, Left Ventricular; Male; Myocardium; Nucleic Acids; Proteins; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Ventricular Function, Left | 1993 |
Cost containment for treating hypertension in African Americans: impact of a combined ACE inhibitor-calcium channel blocker.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Black People; Calcium Channel Blockers; Cost Control; Cost Savings; Drug Combinations; Drug Costs; Humans; Hypertension; Managed Care Programs; Medicaid; Patient Compliance; Therapeutic Equivalency; United States | 1997 |
Combined effects of an angiotensin converting enzyme inhibitor and a calcium antagonist on renal injury.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Calcium Channel Blockers; Disease Models, Animal; Drug Therapy, Combination; Glomerulosclerosis, Focal Segmental; Kidney; Male; Nephrectomy; Proteinuria; Random Allocation; Rats; Rats, Sprague-Dawley | 1997 |
Relationship between endothelial function and fibrinolysis in early hypertension.
Topics: Adult; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Blood Pressure; Brachial Artery; Calcium Channel Blockers; Carotid Arteries; Cholesterol; Echocardiography; Endothelium, Vascular; Female; Fibrinolysis; Glucose Tolerance Test; Hemostasis; Humans; Hyperemia; Hypertension; Insulin; Male; Middle Aged; Plasminogen Activator Inhibitor 1; Reference Values; Regression Analysis; Tissue Plasminogen Activator; Triglycerides | 1998 |
Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Costs and Cost Analysis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Felodipine; Female; Humans; Hypertension; Male; Middle Aged; Nifedipine; Treatment Outcome | 2001 |
Efficacy and safety of a therapeutic interchange from high-dose calcium channel blockers to a fixed-dose combination of amlodipine/benazepril in patients with moderate-to-severe hypertension.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Health Care Costs; Humans; Hypertension; Safety; Treatment Outcome | 2002 |
The effects of antihypertensive agents on the survival rate of polycystic kidney disease in Han:SPRD rats.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Body Weight; Kidney; Kidney Tubules; Male; Polycystic Kidney, Autosomal Dominant; Proteinuria; Rats; Rats, Sprague-Dawley; Survival Analysis | 2002 |
[Vasopressin analogue injection as ultimate measure for counteracting severe catecholamine-refractory poisoning by several vasodilators taken with suicidal intent].
Topics: Adrenergic alpha-Antagonists; Aged; Amlodipine; Angiography; Angiotensin-Converting Enzyme Inhibitors; Arginine Vasopressin; Benzazepines; Female; Heart Rate; Hemodynamics; Humans; Infusions, Intravenous; Injections, Intravenous; Isosorbide Dinitrate; Mesenteric Arteries; Mianserin; Mirtazapine; Poisoning; Suicide, Attempted; Time Factors; Vasoconstrictor Agents; Vasodilator Agents | 2003 |
Effects of antihypertensive drugs on peritoneal vessels in hypertensive dogs with mild renal insufficiency.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Animals; Antihypertensive Agents; Aquaporins; Benzazepines; Blood Pressure; Calcium Channel Blockers; Dogs; Hypertension, Renovascular; Imidazoles; Microcirculation; Olmesartan Medoxomil; Peritoneum; Renal Insufficiency; Tetrazoles; Vasodilation | 2003 |
The Avoiding Cardiovascular events through COMbination therapy in Patients Living with Systolic Hypertension (ACCOMPLISH) trial: a comparison of first-line combination therapies.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Cardiovascular Diseases; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Risk Factors | 2005 |
HPTLC method for the simultaneous determination of amlodipine and benazepril in their formulations.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Chromatography, High Pressure Liquid; Chromatography, Thin Layer; Drug Combinations; Quality Control; Reproducibility of Results | 2005 |
Stability indicating RP-HPLC method for simultaneous determination of amlodipine and benazepril hydrochloride from their combination drug product.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Drug Combinations; Hydrolysis; Oxidative Stress; Reference Standards; Reproducibility of Results; Sensitivity and Specificity; Spectrophotometry, Ultraviolet | 2005 |
Orolingual angioedema associated with ACE inhibitor use after rtPA treatment of acute stroke.
Topics: Acute Disease; Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Dexamethasone; Drug Interactions; Histamine Antagonists; Humans; Infarction, Middle Cerebral Artery; Male; Middle Aged; Mouth; Stroke; Tissue Plasminogen Activator; Tongue; Treatment Outcome | 2005 |
Beneficial effects of combined benazepril-amlodipine on cardiac nitric oxide, cGMP, and TNF-alpha production after cardiac ischemia.
Topics: Amlodipine; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Calcium Channel Blockers; Cyclic GMP; Drug Therapy, Combination; Gene Expression Regulation; Interleukin-6; Male; Myocardial Ischemia; NF-kappa B; Nitric Oxide; Rats; Rats, Inbred Lew; RNA, Messenger; Tumor Necrosis Factor-alpha | 2006 |
Benazepril combined with either amlodipine or hydrochlorothiazide is more effective than monotherapy for blood pressure control and prevention of end-organ injury in hypertensive Dahl rats.
Topics: Acetylcholine; Administration, Oral; Amlodipine; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Hydrochlorothiazide; Hypertension; Male; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary; Vasodilation | 2006 |
Angiotensin II type 2 receptor expression after vascular injury: differing effects of angiotensin-converting enzyme inhibition and angiotensin receptor blockade.
Topics: Amlodipine; Angiotensin II Type 2 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Benzazepines; Blood Pressure; Carotid Artery, Common; Cyclic GMP; Male; Rats; Rats, Inbred BN; Receptor, Angiotensin, Type 2; Tetrazoles; Tunica Intima; Tunica Media; Valine; Valsartan | 2006 |
Angiotensin-converting enzyme (ACE) inhibitor-associated angioedema of the stomach and small intestine: a case report.
Topics: Amlodipine; Angioedema; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Female; Humans; Hypertension; Intestine, Small; Middle Aged; Stomach; Tomography, X-Ray Computed | 2006 |
Compliance with antihypertensive therapy in the elderly: a comparison of fixed-dose combination amlodipine/benazepril versus component-based free-combination therapy.
Topics: Age Factors; Aged; Aged, 80 and over; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Cohort Studies; Dihydropyridines; Drug Combinations; Drug Therapy, Combination; Female; Health Care Costs; Humans; Hypertension; Longitudinal Studies; Male; Medicaid; Patient Compliance; Retrospective Studies; South Carolina; United States | 2008 |
[Amlodipine is the better partner].
Topics: Aged; Amlodipine; Antihypertensive Agents; Benzazepines; Blood Pressure; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Randomized Controlled Trials as Topic; Treatment Outcome | 2008 |
A stunning day in hypertension research - Results of ONTARGET, ACCOMPLISH and HYVET.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Benzimidazoles; Benzoates; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Hypertension; Indapamide; Perindopril; Ramipril; Telmisartan | 2008 |
[Unexpected study data for treatment of hypertension. Combination therapy with a diuretic not imperative].
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Cardiovascular Diseases; Cause of Death; Drug Combinations; Humans; Hydrochlorothiazide; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic; Sodium Chloride Symporter Inhibitors; Survival Analysis | 2008 |
Does it matter how hypertension is controlled?
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Cardiovascular Diseases; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Risk | 2008 |
All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Chlorthalidone; Diuretics; Humans; Hydrochlorothiazide; Hypertension; Multicenter Studies as Topic; Randomized Controlled Trials as Topic | 2009 |
[The ACCOMPLISH trial: are results really unexpected?].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Diuretics; Humans; Hydrochlorothiazide; Hypertension; Randomized Controlled Trials as Topic | 2009 |
Will the results of the ACCOMPLISH trial affect the recommendations of JNC 8?
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Benzazepines; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Practice Guidelines as Topic; Practice Patterns, Physicians'; Randomized Controlled Trials as Topic; Research Design; Treatment Outcome | 2009 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Chlorthalidone; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension; Hypokalemia | 2009 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2009 |
Benazepril plus amlodipine or hydrochlorothiazide for hypertension.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Diuretics; Drug Therapy, Combination; Humans; Hydrochlorothiazide; Hypertension | 2009 |
[Clinical study of the month. The ACCOMPLISH study: challenging the choice of antihypertensive medications in systolic hypertensive patients with high cardiovascular risk].
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Cardiovascular Diseases; Humans; Hypertension; Randomized Controlled Trials as Topic; Systole | 2009 |
Simultaneous determination of amlodipine besylate and benazepril hydrochloride in pharmaceutical dosage form by LC.
Topics: Amlodipine; Benzazepines; Capsules; Chromatography, Liquid; Limit of Detection; Linear Models; Reproducibility of Results; Time Factors | 2009 |
Composite renal endpoints: was ACCOMPLISH accomplished?
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Calcium Channel Blockers; Creatinine; Disease Progression; Diuretics; Drug Therapy, Combination; Glomerular Filtration Rate; Humans; Hydrochlorothiazide; Hypertension; Kidney Failure, Chronic; Renin-Angiotensin System | 2010 |
Hypertension: antihypertensive class matters for combination therapy.
Topics: Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Drug Therapy, Combination; Humans; Hypertension; Renin-Angiotensin System; Vasodilator Agents | 2010 |
Simultaneous determination of atorvastatin, amlodipine, ramipril and benazepril in human plasma by LC-MS/MS and its application to a human pharmacokinetic study.
Topics: Amlodipine; Anticholesteremic Agents; Antihypertensive Agents; Atorvastatin; Benzazepines; Chromatography, Liquid; Drug Stability; Heptanoic Acids; Humans; Least-Squares Analysis; Male; Nevirapine; Pyrroles; Ramipril; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2011 |
Comparative study between univariate spectrophotometry and multivariate calibration as analytical tools for quantitation of Benazepril alone and in combination with Amlodipine.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Calibration; Least-Squares Analysis; Multivariate Analysis; Pharmaceutical Preparations; Principal Component Analysis; Spectrophotometry | 2014 |
[Simultaneous determination of amlodipine, benazepril and benazeprilat in human plasma by LC-HESI/MS/MS method].
Topics: Administration, Oral; Amlodipine; Benzazepines; Chromatography, Liquid; Humans; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry | 2014 |
Development, optimization and validation of a highly sensitive UPLC-ESI-MS/MS method for simultaneous quantification of amlodipine, benazeprile and benazeprilat in human plasma: application to a bioequivalence study.
Topics: Amlodipine; Benzazepines; Chromatography, High Pressure Liquid; Humans; Plasma; Reproducibility of Results; Sensitivity and Specificity; Spectrometry, Mass, Electrospray Ionization; Tandem Mass Spectrometry; Therapeutic Equivalency | 2014 |
Development and validation of different methods manipulating zero order and first order spectra for determination of the partially overlapped mixture benazepril and amlodipine: A comparative study.
Topics: Amlodipine; Antihypertensive Agents; Benzazepines; Capsules; Drug Combinations; Limit of Detection; Powders; Spectrophotometry | 2016 |
Prior Medications and the Cardiovascular Benefits From Combination Angiotensin-Converting Enzyme Inhibition Plus Calcium Channel Blockade Among High-Risk Hypertensive Patients.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzazepines; Blood Pressure; Calcium Channel Blockers; Cause of Death; Drug Therapy, Combination; Female; Humans; Hydrochlorothiazide; Hypertension; Male; Middle Aged; Randomized Controlled Trials as Topic; Risk Assessment; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors; Treatment Outcome | 2018 |
Visual outcome in cats with hypertensive chorioretinopathy.
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzazepines; Blindness; Cat Diseases; Cats; Choroid Diseases; Female; Hypertension; Hypertensive Retinopathy; Male; Prognosis; Treatment Outcome; Vision, Ocular | 2019 |
[The influence of benazepril and amlodipine on the expression of secretin and somatostatin in spontaneously hypertensive rats].
Topics: Amlodipine; Animals; Antihypertensive Agents; Benzazepines; Blood Pressure; Hypertension; Male; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Secretin; Somatostatin | 2018 |
A new strategy for taste masking on bitter drug by other combined drug in fixed-dose combination: bitterness of Amlodipine besylate could be masked efficiently by Valsartan.
Topics: Amlodipine; Benzazepines; Captopril; Dose-Response Relationship, Drug; Humans; Hydrochlorothiazide; Taste; Taste Perception; Telmisartan; Valsartan | 2019 |